Aadi Bioscience Operating Profit Margin Over Time
| AADI Stock | USD 1.98 0.05 2.59% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Aadi Bioscience Performance and Aadi Bioscience Correlation. Aadi |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.28) | Revenue Per Share | Quarterly Revenue Growth 0.21 | Return On Assets | Return On Equity |
The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Operating Profit Margin Analysis
Compare Aadi Bioscience and related stocks such as Anebulo Pharmaceuticals, Adagene, and Acrivon Therapeutics, Operating Profit Margin Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ANEB | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ADAG | (11.4709) | (11.4709) | (11.4709) | (11.4709) | (11.4709) | (11.4709) | (11.4709) | (11.4709) | (11.4709) | (39.9368) | (39.9368) | (7.1118) | (9.0308) | (1.3097) | (1.18) | (1.24) |
| ACRV | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ANAB | (0.9643) | (0.9643) | (0.9643) | (0.9643) | 0.3075 | (0.1891) | (0.1813) | (2.8781) | (13.3444) | (13.429) | (0.3184) | (0.8993) | (11.1941) | (9.5827) | (1.2593) | (1.32) |
| MLYS | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ANTX | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| AVTE | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| GLUE | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| DSGN | (2.3 K) | (2.3 K) | (2.3 K) | (2.3 K) | (2.3 K) | (2.3 K) | (2.3 K) | (2.3 K) | (2.3 K) | (2.3 K) | (36.9 K) | (36.9 K) | (36.9 K) | (36.9 K) | (42.4 K) | (44.5 K) |
| ERAS | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| RZLT | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| RARE | (1.9 K) | (1.9 K) | (1.9 K) | (1.9 K) | (1.9 K) | (1.9 K) | (1.9 K) | (126) | (7.2118) | (4.0898) | (1.218) | (1.0863) | (1.786) | (1.3108) | (0.9567) | (1.0) |
| CRNX | (10.2615) | (10.2615) | (10.2615) | (10.2615) | (10.2615) | (10.2615) | (10.2615) | (4.4631) | (11.8245) | (45.1232) | (1.1 K) | (99.9091) | (35.4406) | (55.4717) | (326) | (342) |
| ARVN | (2.4695) | (2.4695) | (2.4695) | (2.4695) | (2.4695) | (2.4695) | (2.4695) | (3.267) | (3.058) | (1.1989) | (5.7269) | (4.182) | (2.003) | (5.1146) | (0.9499) | (1.0) |
| RVMD | (2.0) | (2.0) | (2.0) | (2.0) | (2.0) | (2.0) | (2.0) | (2.0) | (2.0) | (1.0815) | (2.5754) | (6.397) | (7.3001) | (42.0712) | (48.38) | (45.96) |
| KURA | (3.5855) | (3.5855) | (3.5855) | (3.5855) | (3.5855) | (3.5855) | (3.5855) | (3.5855) | (3.5855) | (3.5855) | (3.5855) | (3.5855) | (3.5855) | (3.5855) | (3.23) | (3.39) |
Aadi Bioscience and related stocks such as Anebulo Pharmaceuticals, Adagene, and Acrivon Therapeutics, Operating Profit Margin description
My Equities
My Current Equities and Potential Positions
| Aadi Bioscience | AADI |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 1.98
Check out Aadi Bioscience Performance and Aadi Bioscience Correlation. For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Aadi Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.